Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1049
-
Total 13F shares, excl. options
-
73M
-
Shares change
-
+192K
-
Total reported value, excl. options
-
$36.6B
-
Value change
-
+$95.6M
-
Put/Call ratio
-
0.74
-
Number of buys
-
446
-
Number of sells
-
-445
-
Price
-
$502.23
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2023
1,150 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2023.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,049 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73M shares
of 80.8M outstanding shares and own 90.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.65M shares), VANGUARD GROUP INC (8.25M shares), STATE STREET CORP (3.77M shares), ALLIANCEBERNSTEIN L.P. (3.59M shares), Fundsmith LLP (2.96M shares), BAMCO INC /NY/ (2.38M shares), GEODE CAPITAL MANAGEMENT, LLC (2.01M shares), FRANKLIN RESOURCES INC (1.45M shares), Invesco Ltd. (1.24M shares), and BLAIR WILLIAM & CO/IL (1.19M shares).
This table shows the top 1049 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.